Role of Immunoscore® in Stage II-III Colorectal Cancer

D

D'Or Institute for Research and Education

Status

Enrolling

Conditions

Colon Adenocarcinoma

Treatments

Diagnostic Test: Immunoscore Colon Test

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT05422547
Immunoscore®

Details and patient eligibility

About

The proposed study is a bidirectional analytical study, composed of a retrospective and a prospective cohorts. Patients with stage II - III colorectal cancer undergoing oncological surgery will be analyzed. The study will include a convenience sample of 100 individuals. Fifty cases will be included retrospectively and fifty prospectively. The study aims to evaluate the benefit of using the Immunoscore test as a predictor of recurrence in patients with operated stage II-III colon tumors. It will also be evaluated the impact on oncologic decision and costs.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Anatomopathological diagnosis of colorectal adenocarcinoma
  • Stage II - III (AJCC 8th edition)
  • Patient undergoing surgery with curative intent

Exclusion criteria

  • Current or previous diagnosis (within the last 5 years) of another invasive primary malignant neoplasm, with the exception of non-melanoma skin neoplasm
  • Presence of distant metastatic disease evidenced in imaging tests

Trial contacts and locations

2

Loading...

Central trial contact

Camila M Moniz, PhD; Ingrid P Barbosa

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems